DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Anderson D, Phan C, Johnston WS. et al.
Rituximab in refractory myasthenia gravis: a prospective, open-label study with long-term follow-up.
Ann Clin Transl Neurol 2016;
3: 552-555
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.